OHE23h
OHE’s submission for the DHSC’s next 10 years of planning
This Insight summarises the recommendations OHE submitted towards the Department of Health & Social Care’s consultation on ...
OHE6d
Dilek Sernur Eminoğulları
Dilek is a senior health policy expert who has held various positions including Deputy General Manager at the Social Security Institution of Türkiye. She holds a master’s degree in International ...
OHE9d
Sarin KC
Sarin KC is the Head of the Environmental Economics Unit at the Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand. As a health economist, he has ...
OHE16d
Latest estimates show that 20 people a day die in unrelieved pain across the UK at the end of their lives
To help inform the current debate on assisted dying, we have updated the findings of our 2019 palliative report with the latest data. A previous OHE report in 2019 estimated that 378, 427 people in ...
OHE22d
Bhaven N. Sampat
Bhaven N. Sampat is an economist by training, a Professor at the Department of Health Policy and Management at Columbia University, and a Research Associate at the National Bureau of Economic Research ...
OHE23d
What is the impact of Uniform Pricing, Indication-Based Pricing (IBP) and alternative commercial arrangements for new pharmaceuticals in the UK NHS?
For the growing number of multi-indication medicines, challenges arise in assessing and paying for value across medicine indications with a uniform price (see our previous report and further ...
OHE28d
Understanding societal preferences for priority by disease severity in England & Wales
The National Institute for Health and Care Excellence (NICE)’s severity modifier assigns greater weight to health gains to patients with more severe diseases, making it more likely that treatments for ...